Archive | Biopharmaceuticals

2019 J.P.Morgan Healthcare Notes #1 Panel: Reinventing the Disease Continuum Through Precision Health…Update

Update-1…1/21/19 Liquid Biopsy I attended a Panel Session on Cancer Liquid Biopsy and although progress is being made on molecular diagnostics there are no newsworthy breakthroughs nor actual data showing a hard timeline. Here is an article from  BIO 2016. There are over 70 genes that need to be tested and voluminous data is being generated […]

Continue Reading 0

Big Biopharma Bounce off Bottom: Mid Caps…Updates

1/7/19 …After Close: Most Mid-Caps held gains but check AH trading Selected Winners today: AGIO 8.7%, ALNY 8.75%, ARRY 8.85%, BLUE 6.67%, BPMC 14.1%, NKTR 7.83%, SGEN 5.68%, ICPT 7.28%, XBI 5.97% (closed at highs. $79.50). Many of these mid-caps are still at low end of 52 week range. Selected stocks above 52 week mid-range: […]

Continue Reading 0

Large Cap Biopharmaceutical Performance 2018…Updates BMY CELG, XBI

1/7/19 After Close: Both BMY and CELG held today up over 3%. ==== Stay tuned Next Week for Updates from the J.P.Morgan Healthcare Conference 1/5/19 Friday’s broad-based biopharmaceutical rally boosts stocks out of a “Bear Market”which brought the XBI down 25% off highs to the  $64 level on December 24, 2018 and now at $75. […]

Continue Reading 0

Free Falling Biotech Stocks Hit New 52 Week Lows…Updates 12/29

Update: 12/29/18 Biotech Stocks Halt Slide: IBB down 0.34% to $94.84 and up 4.7% for the week, XBI up 0.73% to $70.09 and up 5.6% for the week. XLV up 3.5% for the week to $85.25.Volatile market trying to hold DEC 24 bottom. Recent trades that worked: ABBV AMGN ; did not work ALXN CELG […]

Continue Reading 0

Bull Case for Biotech Remains Elusive-Trade Carefully…Update after FED Meeting

Update-2 After close: Market Collapses After FED Meeting-Bear Market  WE all knew that the biotech sector likes looser monetary policy but this sell-off is ridiculous. The IBB is now at May 2017 levels! XBI breaks through 2018 technicals down 3.33% on downside to $71.20, now at June 2017 lows. Update-1 1 pm 12/19/18 Green Day […]

Continue Reading 0

Trade Fears Derail Biotech Rally in a Jittery Market…Updates

Update -4 After Close 12/7/18 Market Performance for the Week XBI down 7.8%, IBB down 6.6%, XLV down 5.2%, QQQ down 5.11%. Futures not looking good at 12:40a EST, NAZ down 0.82%. Global Growth worries mount; geopolitical turmoil reigns. Moderna (MRNA) IPO closes down 19.13% to $18.60: Largest Biotech to Go Public…https://finance.yahoo.com/news/nasdaq-welcomes-moderna-inc-nasdaq-185435974.html ======= Update-3 After […]

Continue Reading 0

Trading the Biotech Bottom in 2018 in an Ambivalent Market…Updates ASH TSRO XBI

Update-2 December 3 …Our Top Pick TSRO is up 58% on GSK Buyout We recommended Tesaro (TSRO) at $34 and it paid off today with a ~$5.1B buyout by GlaxoSmith Kline! Year End Rally Intact with XBI up over 3% to $84 handle, ====== Update-1 December 1… NASDAQ Rallies 0.79% on Nov 30 Our recent […]

Continue Reading 0

Trade the Seasonal Rally in Biotech Off the 2018 Bottom…Updates AMGN TSRO XBI

Update for the Week: Trying to Find the Bottom-Choppy Action But Tradeable XBI holds above $74.62 bottom up 1.3% for the week but can’t hold today’s gains. AMGN flat for the week at $193 but can’t hold gains at mid-week. Big winner TSRO up 64.9% for week now at $43. Tape looking better with more green […]

Continue Reading 0

2018 Biopharmaceutical Performance-Large Caps: Big winners were Merck and Vertex…Update- Rally Underway

11/16…TSRO Alert at $35, Up 32%, Company is for Sale 11/15p After Close…Traders: Rally is intact but needs another green day to confirm. Big mid-cap 4% movers today: AGIO ARNA (up 21.6%) ARRY CRSP LOXO NBIX ICPT SRPT  XNCR We added small positions over the past week in ABBV AMRN KPTI QQQ XLV and XBI as […]

Continue Reading 0

Biotech Bear Market: But It Is Time to Start Trading…11/9 Updates on Rally

Update at Close 11/9/18 Remain Cautious as Rally Fails The NASDAQ down 1.6% and Russell 2000 down 1.8%, sold off killing hopes of a continued Post-Election rally. The biotech sector is for experienced traders only. The healthcare still looks good overall with the XLV down only 0.29% at $92.95. The XBI was crushed again down […]

Continue Reading 0